Now showing items 1-17 of 17
| Title | Author(s) | Journal | Issue Date | Type |
|---|---|---|---|---|
| Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference | Wahren, B.; Biswas, P.; Borggren, M.; Coleman, A.; Da Costa, K.; De Haes, W.; Dieltjens, T.; Dispinseri, S.; Grupping, K.; Hallengard, D.; Hornig, J.; Klein, K.; Mainetti, L.; Palma, P.; Reudelsterz, M.; Seifried, J.; Selhorst, P.; Skold, A.; van Gils, M. J.; Weber, C.; Shattock, R.; Scarlatti, G. | Journal of Translational Medicine | 2010 | Article-E |
| Assessment of mucosal immunity to HIV-1 | Jespers, V.; Harandi, A. M.; Hinkula, J.; Medaglini, D.; Le Grand, R.; Stahl-Hennig, C.; Bogers, W.; El Habib, R.; Wegmann, F.; Fraser, C.; Cranage, M.; Shattock, R. J.; Spetz, A. L. | Expert Review of Vaccines | 2010 | Article |
| Buruli ulcer disease: prospects for a vaccine | Huygen, K.; Adjei, O.; Affolabi, D.; Bretzel, G.; Demangel, C.; Fleisher, B.; Johnson, R. C.; Pedrosa, J.; Phanzu, D. M.; Phillips, R. O.; Pluschke, G.; Siegmund, V.; Singh, M.; van der Werf, T. S.; Wansbrough-Jones, M.; Portaels, F. | Medical Microbiology and Immunology | 2009 | Article |
| International network for comparison of HIV neutralization assays: the NeutNet report | Fenyö, E. M.; Heath, A.; Dispinseri, S.; Holmes, H.; Lusso, P.; Zolla-Pazner, S.; Donners, H.; Heyndrickx, L.; Alcami, J.; Bongertz, V.; Jassoy, C.; Malnati, M.; Montefiori, D.; Moog, C.; Morris, L.; Osmanov, S.; Polonis, V.; Sattentau, Q.; Schuitemaker, H.; Sutthent, R.; Wrin, T.; Scarlatti, G. | PLoS ONE | 2009 | Article-E |
| Production of human immunodeficiency virus type 1 (HIV-1) pseudoviruses using linear HIV-1 envelope expression cassettes | Beels, D.; Heyndrickx, L.; Vereecken, K.; Vermoesen, T.; Michiels, L.; Vanham, G.; Kestens, L. | Journal of Virological Methods | 2008 | Article |
| Biomedical interventions to prevent HIV infection: evidence, challenges, and way forward | Padian, N. S.; Buvé, A.; Balkus, J.; Serwadda, D.; Cates, W. | Lancet | 2008 | Article |
| Buruli ulcer (M. ulcerans infection): new insights, new hope for disease control | Johnson, P. D. R.; Stinear, T.; Small, P. L. C.; Pluschke, G.; Merritt, R. W.; Portaels, F.; Huygen, K.; Hayman, J. A.; Asiedu, K. | PLoS Medicine | 2005 | Article |
| Neutralization of primary HIV-1 SF13 can be detected in extended incubation phase assays with sera from monkeys immunized with recombinant HIV-1 SF2 gp120 | Davis, D.; Donners, H.; Willems, B.; Lövgren-Bengtsson, K.; Akerblom, L.; Vanham, G.; Barnett, S.; Morein, B.; Heeney, J. L.; van der Groen, G. | Vaccine | 2004 | Article |
| Actieve immunotherapie voor HIV-1-infectie | Van den Bosch, G.; Ponsaerts, P.; Van Tendeloo, V.; Van Bockstaele, D.; Vanham, G.; Berneman, Z. N. | Tijdschrift voor Geneeskunde | 2004 | Article |
| [Study of development of HIV vaccine by HIV subspecies analysis] | Ishikawa, K.; Takebe, Y.; Kojima, N.; van der Groen, G.; Ferreira, W. F. C.; Ofori-Adjei, D. | Kokusai Kenkyu Guranto Jigyo Kenkyu Hokokusho | 2003 | Article |
| The first generation of candidate HIV-1 vaccines can induce antibodies able to neutralize primary isolates in assays with extended incubation phases | Donners, H.; Vermoesen, T.; Willems, B.; Davis, D.; van der Groen, G. | Vaccine | 2003 | Article |
| Scientific considerations for the regulation and clinical evaluation of HIV/AIDS preventive vaccines; report from a WHO-UNAIDS Consultation 13-15 March 2001, Geneva, Switzerland | Unknown author | AIDS | 2002 | Article |
| [Development of the HIV vaccine by the subspecies analysis (human science promotion foundation S)] | Ishikawa, K.; Takebe, Y.; Mizuochi, T.; Naoya, K.; Ofori-Adjei, D.; van der Groen, G.; Wanda, F | Kokusai Kenkyu Guranto Jigyo Kenkyu Hokokusho | 2002 | Article |
| Protective efficacy of a DNA vaccine encoding antigen 85 A from Mycobacterium bovis BCG against Buruli ulcer | Tanghe, A.; Content, J.; Van Vooren, J. P.; Portaels, F.; Huygen, K. | Infection and Immunity | 2001 | Article |
| New insights into protective humoral responses and HIV vaccines | Stamatatos, L.; Davis, D. | AIDS | 2001 | Article |
| Approaches to the development of broadly protective HIV vaccines: challenges posed by the genetic, biological and antigenic variability of HIV-1 | Unknown author | AIDS | 2001 | Article |
| Evidence for viral virulence as a predominant factor limiting human immunodeficiency virus vaccine efficacy | Mooij, P.; Bogers, W. M.; Oostermeijer, H.; Koornstra, W.; ten Haaft, P. J.; Verstrepen, B. E.; Van der Auwera, G.; Heeney, J. L. | Journal of Virology | 2000 | Article |
Now showing items 1-17 of 17